Fumiko Oda

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis

Adequate tacrolimus concentration for myasthenia gravis treatment